Literature DB >> 15746662

Proteomic biomarkers that predict the clinical success of rescue cerclage.

Carl P Weiner1, Keun-Young Lee, Catalin S Buhimschi, Rob Christner, Irina A Buhimschi.   

Abstract

OBJECTIVE: The origin of incompetent cervix is multifactorial, and the success of rescue cerclage is unpredictable. We tested amniotic fluid from women who were preparing to undergo rescue cerclage for proteomic biomarkers and correlated their presence with clinical outcome. STUDY
DESIGN: Amniocentesis was performed to facilitate rescue cerclage in 37 consecutive women with painless dilation (> 2 cm) and no detectable uterine activity for 4 hours (range, 1-24 hours) before cerclage. Thirty-nine consecutive women with a sonographically normal pregnancy and cervix who underwent amniocentesis for chromosomal testing during the same study interval at the same clinical site provided the control samples. A proteomic fingerprint was generated with the discarded sample and the Mass-Restricted score (MR score) for inflammation calculated. Peaks corresponding to free hemoglobin chains were sought as evidence of decidual hemorrhage or intra-amniotic bleeding.
RESULTS: Amniocentesis was performed at 23.5 weeks in cerclage (mean dilation, 4 cm) versus 19.5 weeks in control subjects. Cerclage subjects were delivered at 28.8 weeks; control subjects were delivered at 39.2 weeks. Thirty-two of 37 of cerclage subjects (86%) were delivered prematurely. Ten of 37 of cerclage subjects (27%), but no control subject, had a MR score that was indicative of inflammation (P < .001). Hemoglobin peaks were present in 12 of 37 of cerclage subject (32%), but no control subjects. Among cerclage subjects, those with a MR score of 3 to 4 were delivered earlier than those with a MR score of 0 to 2 (P < .001). Women with a MR score of 3 to 4 had a shorter latency period (days from amniocentesis to delivery; 3 days) and a shorter percentage of prolongation (1.8%) than women with a MR score of 0 to 2 (35 days; P < .05; 17.9%; P < .05). Women with hemoglobin had a shorter latency period (6 days) and a shorter percentage of prolongation (3.8%) than women without hemoglobin (38 days; P < .05; 21.8%; P < .05). Hemoglobin was present in 7 of 10 of the cerclage subjects (70%) with a MR score of 3 to 4. Women with both a MR score of 3 to 4 and hemoglobin had the shortest intervals to delivery.
CONCLUSION: These findings illustrate 2 pathologic mechanisms that are associated with preterm delivery are also associated with incompetent cervix. Either an intrauterine inflammatory response or decidual hemorrhage predates surgery in one half the women whose condition requires rescue cerclage. The activation of either mechanism predicts cerclage failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746662     DOI: 10.1016/j.ajog.2004.10.588

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

Review 1.  Amniotic fluid: the use of high-dimensional biology to understand fetal well-being.

Authors:  Beena D Kamath-Rayne; Heather C Smith; Louis J Muglia; Ardythe L Morrow
Journal:  Reprod Sci       Date:  2013-04-18       Impact factor: 3.060

2.  Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.

Authors:  Irina A Buhimschi; Catalin S Buhimschi; Carl P Weiner; Tatsuji Kimura; Benjamin D Hamar; Anna K Sfakianaki; Errol R Norwitz; Edmund F Funai; Elena Ratner
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 3.  The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.

Authors:  Irina A Buhimschi; Catalin S Buhimschi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

4.  Using SELDI-TOF mass spectrometry on amniotic fluid and for clinical proteomics and theranostics in disorders of pregnancy.

Authors:  Irina A Buhimschi
Journal:  Methods Mol Biol       Date:  2012

5.  Bleeding per vaginam is associated with funisitis in women with preterm prelabour rupture of the fetal membranes.

Authors:  C A Grotegut; L N C Johnson; C B Fitzpatrick; R P Heine; G K Swamy; A P Murtha
Journal:  BJOG       Date:  2011-03-10       Impact factor: 6.531

Review 6.  Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future.

Authors:  Catalin S Buhimschi; Vineet Bhandari; Yiping W Han; Antonette T Dulay; Margaret A Baumbusch; Joseph A Madri; Irina A Buhimschi
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

7.  Total hemoglobin concentration in amniotic fluid is increased in intraamniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Francesca Gotsch; Nandor G Than; Shali Mazaki-Tovi; Pooja Mittal; Sam Edwin; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

8.  Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth.

Authors:  C S Buhimschi; A T Dulay; S Abdel-Razeq; G Zhao; S Lee; E J Hodgson; V Bhandari; I A Buhimschi
Journal:  BJOG       Date:  2008-10-08       Impact factor: 6.531

Review 9.  Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth.

Authors:  I A Buhimschi; C S Buhimschi
Journal:  Placenta       Date:  2008-01-11       Impact factor: 3.481

Review 10.  Relationships between mechanical properties and extracellular matrix constituents of the cervical stroma during pregnancy.

Authors:  Michael House; David L Kaplan; Simona Socrate
Journal:  Semin Perinatol       Date:  2009-10       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.